nach oben

Drug Safety

Erschienen in:

01.07.2007 | Conference Paper

Thoughts on Signal Detection in Pharmacovigilance

verfasst von: Professor Saad A.W. Shakir

Erschienen in: Drug Safety | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Excerpt

“We shouldn’t overload the disproportionality methods; putting them in perspective will provide the maximum benefit.” …

McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; 278(7216): 1358CrossRef

Shakir SAW. Prescription-event monitoring. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester: John Wiley & Sons Ltd; 2005. 203–16

Jick H. The discovery of drug-induced illness. N Engl J Med 1977; 296(9): 481–5PubMedCrossRef

Clarke A, Deeks JJ, Shakir SAW. An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf 2006; 29(2): 175–81PubMedCrossRef

Titel: Thoughts on Signal Detection in Pharmacovigilance
verfasst von: Professor Saad A.W. Shakir
Publikationsdatum: 01.07.2007
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 7/2007
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200730070-00005

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2007

Principles of Data Mining

Standardised MedDRA Queries

Prescription-Event Monitoring

You’ve Found a Safety Signal —Now What?

Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy

Signal Detection in the Pharmaceutical Industry